Quantity
The number of sponsors and projects rises continuously. To date more than 50,000 patients in 50+ simultaneous trials have already been documented in MARVIN (completed and ongoing trials). The demand for consulting is also on the increase.
The XClinical employees have provided consulting expertise to several major pharma and medical device manufacturers for EDC selection and implementation.

